SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-20-007809
Filing Date
2020-05-14
Accepted
2020-05-14 16:36:57
Documents
50
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgls20200331-10q.htm 10-Q 918162
2 EXHIBIT 10.1 ex-101x20200331.htm EX-10.1 134167
3 EXHIBIT 31.1 ex-311x20200331.htm EX-31.1 12046
4 EXHIBIT 31.2 ex-312x20200331.htm EX-31.2 12023
5 EXHIBIT 32.1 ex-321x20200331.htm EX-32.1 11808
  Complete submission text file 0001628280-20-007809.txt   4420054

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rgls-20200331.xml EX-101.INS 632040
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rgls-20200331.xsd EX-101.SCH 35559
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rgls-20200331_cal.xml EX-101.CAL 53814
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rgls-20200331_def.xml EX-101.DEF 225404
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rgls-20200331_lab.xml EX-101.LAB 528085
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rgls-20200331_pre.xml EX-101.PRE 302592
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 20878398
SIC: 2834 Pharmaceutical Preparations